Targeting Rho and Rho-kinase in the treatment of cardiovascular disease
- 1 February 2006
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 27 (2) , 97-104
- https://doi.org/10.1016/j.tips.2005.12.002
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Impaired Endothelium-Dependent Responses and Enhanced Influence of Rho-Kinase in Cerebral Arterioles in Type II DiabetesStroke, 2005
- Angiotensin II–Induced Vascular Dysfunction Is Mediated by the AT 1A Receptor in MiceHypertension, 2004
- Rho/Rho-Kinase Pathway in the Brainstem Contributes to Hypertension Caused by Chronic Nitric Oxide Synthase InhibitionHypertension, 2004
- Smoking Activates Rho-Kinase in Smooth Muscle Cells of Forearm Vasculature in HumansHypertension, 2003
- Tumor Necrosis Factor-α–Induced Activation of RhoA in Airway Smooth Muscle Cells: Role in the Ca2+ Sensitization of Myosin Light Chain20 PhosphorylationMolecular Pharmacology, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplantsThe FASEB Journal, 2002
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Neuroprotection mediated by changes in the endothelial actin cytoskeletonJournal of Clinical Investigation, 2000